Retrieved from Eli Lilly-d
As the active ingredient in Mounjaro (approved May 2022 for type 2 diabetes) and Zepbound (approved November 2023 for chronic weight management, expanded December 2024 for obstructive sleep apnea), tirzepatide works by mimicking two natural hormones GLP-1 and GIP that regulate hunger, blood sugar, and metabolism
PlexusDx providers design individualized tapering schedules based on your current dose and genetic profile
Like other weight-loss drugs, its to be used along with exercise, a healthy diet and other steps like keeping a food diary
At 72 weeks, participants receiving Tirzepatide 5mg, 10mg, or 15mg achieved mean weight reductions of 15.0%, 19.5%, and 20.9% respectively, compared to 3.1% with placebo
The Medical Letter Vetrugno L, et al